Advances in the development of thrombin inhibitors

Author： Steinmetzer T. Hauptmann J. Stürzebecher J.

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.10, Iss.5, 2001-05, pp. : 845-864

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development

By Eriksson Bengt I.

Clinical Pharmacokinetics, Vol. 48, Iss. 1, 2009-01 ,pp. : 1-22

Adis International

Access to resources Recommend Favorite

Progress in the Development of Synthetic Thrombin Inhibitors as New Orally Active Anticoagulants

Current Medicinal Chemistry, Vol. 11, Iss. 17, 2004-09 ,pp. : 2297-2321

Bentham Science Publishers

Access to resources Recommend Favorite

Thrombin: Development of factor V and thrombin inhibitors leading to coagulation disorders and haemorrhage in paediatric patients: 3 case reports

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite

Advances in the development of novel aggrecanase inhibitors

By Gilbert Adam M Bikker Jack A O'Neil Steven V

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 1, 2011-01 ,pp. : 1-12

Informa Healthcare

Access to resources Recommend Favorite

Thrombin Receptor Antagonists, Recent Advances in PAR-1 Antagonist Development

Current Medicinal Chemistry, Vol. 9, Iss. 13, 2002-07 ,pp. : 1229-1250

Bentham Science Publishers

Access to resources Recommend Favorite